相似文献
1
Plasma inorganic pyrophosphate and alkaline phosphatase in patients with pseudoxanthoma elasticum.
Ann Transl Med. 2019 Dec;7(24):798. doi: 10.21037/atm.2019.12.73.
2
Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
J Dermatol Sci. 2014 Aug;75(2):109-20. doi: 10.1016/j.jdermsci.2014.04.015. Epub 2014 May 17.
3
Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.
J Dermatol Sci. 2014 Apr;74(1):72-80. doi: 10.1016/j.jdermsci.2013.12.008. Epub 2014 Jan 2.
4
Anticalcification effects of DS-1211 in pseudoxanthoma elasticum mouse models and the role of tissue-nonspecific alkaline phosphatase in ABCC6-deficient ectopic calcification.
Sci Rep. 2022 Nov 18;12(1):19852. doi: 10.1038/s41598-022-23892-5.
5
Lansoprazole Increases Inorganic Pyrophosphate in Patients with Pseudoxanthoma Elasticum: A Double-Blind, Randomized, Placebo-Controlled Crossover Trial.
Int J Mol Sci. 2023 Mar 3;24(5):4899. doi: 10.3390/ijms24054899.
6
Inhibition of Tissue-Nonspecific Alkaline Phosphatase Attenuates Ectopic Mineralization in the Abcc6 Mouse Model of PXE but Not in the Enpp1 Mutant Mouse Models of GACI.
J Invest Dermatol. 2019 Feb;139(2):360-368. doi: 10.1016/j.jid.2018.07.030. Epub 2018 Aug 18.
7
Relationships between Plasma Pyrophosphate, Vascular Calcification and Clinical Severity in Patients Affected by Pseudoxanthoma Elasticum.
J Clin Med. 2022 May 5;11(9):2588. doi: 10.3390/jcm11092588.
8
The Purinergic Nature of Pseudoxanthoma Elasticum.
Biology (Basel). 2024 Jan 26;13(2):74. doi: 10.3390/biology13020074.
9
ABCC6, Pyrophosphate and Ectopic Calcification: Therapeutic Solutions.
Int J Mol Sci. 2021 Apr 27;22(9):4555. doi: 10.3390/ijms22094555.
10
Variants in genes encoding pyrophosphate metabolizing enzymes are associated with Pseudoxanthoma elasticum.
Clin Biochem. 2014 Oct;47(15):60-7. doi: 10.1016/j.clinbiochem.2014.07.003. Epub 2014 Jul 12.
引用本文的文献
1
A Fragile Phosphate/Pyrophosphate Balance: From Essential Mineralization to Rare Calcifying Diseases.
Curr Osteoporos Rep. 2025 Aug 6;23(1):34. doi: 10.1007/s11914-025-00928-z.
2
Investigation on ABCC6-Deficient Human Hepatocytes Generated by CRISPR-Cas9 Genome Editing.
Cells. 2025 Apr 11;14(8):576. doi: 10.3390/cells14080576.
3
A Plasma Pyrophosphate Cutoff Value for Diagnosing Pseudoxanthoma Elasticum.
Int J Mol Sci. 2024 Jun 13;25(12):6502. doi: 10.3390/ijms25126502.
4
Pseudoxanthoma elasticum - Genetics, pathophysiology, and clinical presentation.
Prog Retin Eye Res. 2024 Sep;102:101274. doi: 10.1016/j.preteyeres.2024.101274. Epub 2024 May 28.
5
Histological Findings in the Eyes of Abcc6 Knockout Rat Model of Pseudoxanthoma Elasticum.
Transl Vis Sci Technol. 2024 Apr 2;13(4):29. doi: 10.1167/tvst.13.4.29.
6
The Purinergic Nature of Pseudoxanthoma Elasticum.
Biology (Basel). 2024 Jan 26;13(2):74. doi: 10.3390/biology13020074.
7
Significance of Premature Vertebral Mineralization in Zebrafish Models in Mechanistic and Pharmaceutical Research on Hereditary Multisystem Diseases.
Biomolecules. 2023 Nov 6;13(11):1621. doi: 10.3390/biom13111621.
8
Novel Treatments for PXE: Targeting the Systemic and Local Drivers of Ectopic Calcification.
Int J Mol Sci. 2023 Oct 10;24(20):15041. doi: 10.3390/ijms242015041.
9
Matrix Metalloproteinases Contribute to the Calcification Phenotype in Pseudoxanthoma Elasticum.
Biomolecules. 2023 Apr 12;13(4):672. doi: 10.3390/biom13040672.
10
Inorganic Pyrophosphate Plasma Levels Are Decreased in Pseudoxanthoma Elasticum Patients and Heterozygous Carriers but Do Not Correlate with the Genotype or Phenotype.
J Clin Med. 2023 Feb 27;12(5):1893. doi: 10.3390/jcm12051893.
本文引用的文献
1
Endogenous Calcification Inhibitors in the Prevention of Vascular Calcification: A Consensus Statement From the COST Action EuroSoftCalcNet.
Front Cardiovasc Med. 2019 Jan 18;5:196. doi: 10.3389/fcvm.2018.00196. eCollection 2018.
2
Cellular signaling in pseudoxanthoma elasticum: an update.
Cell Signal. 2019 Mar;55:119-129. doi: 10.1016/j.cellsig.2018.12.009. Epub 2019 Jan 4.
3
Apabetalone downregulates factors and pathways associated with vascular calcification.
Atherosclerosis. 2019 Jan;280:75-84. doi: 10.1016/j.atherosclerosis.2018.11.002. Epub 2018 Nov 14.
4
Inhibition of Tissue-Nonspecific Alkaline Phosphatase Attenuates Ectopic Mineralization in the Abcc6 Mouse Model of PXE but Not in the Enpp1 Mutant Mouse Models of GACI.
J Invest Dermatol. 2019 Feb;139(2):360-368. doi: 10.1016/j.jid.2018.07.030. Epub 2018 Aug 18.
5
Alteration of Extracellular Nucleotide Metabolism in Pseudoxanthoma Elasticum.
J Invest Dermatol. 2018 Aug;138(8):1862-1870. doi: 10.1016/j.jid.2018.02.023. Epub 2018 Mar 6.
6
Discovery of 5-((5-chloro-2-methoxyphenyl)sulfonamido)nicotinamide (SBI-425), a potent and orally bioavailable tissue-nonspecific alkaline phosphatase (TNAP) inhibitor.
Bioorg Med Chem Lett. 2018 Jan 1;28(1):31-34. doi: 10.1016/j.bmcl.2017.11.024. Epub 2017 Nov 11.
7
Oral administration of pyrophosphate inhibits connective tissue calcification.
EMBO Mol Med. 2017 Nov;9(11):1463-1470. doi: 10.15252/emmm.201707532.
8
Plasma PPi Deficiency Is the Major, but Not the Exclusive, Cause of Ectopic Mineralization in an Abcc6 Mouse Model of PXE.
J Invest Dermatol. 2017 Nov;137(11):2336-2343. doi: 10.1016/j.jid.2017.06.006. Epub 2017 Jun 23.
9
Ectopic calcification in pseudoxanthoma elasticum responds to inhibition of tissue-nonspecific alkaline phosphatase.
Sci Transl Med. 2017 Jun 7;9(393). doi: 10.1126/scitranslmed.aal1669.
10
Inherited Arterial Calcification Syndromes: Etiologies and Treatment Concepts.
Curr Osteoporos Rep. 2017 Aug;15(4):255-270. doi: 10.1007/s11914-017-0370-3.
Zotero 插件